R21/Matrix-M ™ Malaria Vaccine with Novavax’s Adjuvant Technology Receives WHO Recommendation

October 2, 2023 - Today, the World Health Organization (WHO) announced its recommendation of the R21/Matrix-M™ malaria vaccine to prevent malaria in children following advice from its Strategic Advisory Group of Experts (SAGE) and Malaria...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials